The homing of hematopoietic precursor cells (HPC) within the bone marrow is most likely to be mediated by specific adhesion via surface receptors to cellular and extracellular matrix (ECM) components and to be regulated by cytokines. We investigated the effects of serum and cytokines on the expression of adhesion molecules on cryopreserved and fresh peripheral blood-derived progenitor cells (PBPC) and on the adhesion of PBPC to various ECM proteins. PBPC were collected from patients by leukapheresis during G-CSF-supported recovery from conventional cancer chemotherapy. 
better understood. Specific adhesion between bone marrow matrix components 1 and HPC via receptors allows close and intricate interactions between HPC and cytokines in vitro (reviewed in Refs 2, 3, 4 and 5) but also in vivo. 6 In the clinical setting of autotransplantation, HPC are subjected to dramatic alterations since these cells are usually frozen, cryopreserved in liquid nitrogen, and finally thawed immediately before transplantation. At the time of transplantation, the cells are fragile with impaired viability. 7, 8 In this study, members from the integrin, selectin and CD44 families of adhesion molecules [9] [10] [11] [12] [13] [14] were analyzed on HPC immediately after cryopreservation and compared with fresh cells. Since the expression of some adhesion molecules was impaired by cryopreservation we asked the question whether short-term incubation in serum alone could restitute the expression of adhesion molecules and also alter adhesion to extracellular matrix molecules.
Cytokines such as G-CSF, when given to patients, foster hematopoietic recovery after high-dose therapy. 15 On the other hand, some cytokines induce mobilization of HPC into the peripheral blood. 16, 17 Although the reasons for these opposing effects are not yet understood it has been shown that the expression and function of adhesion molecules on HPC can be modulated by cytokines. 18, 19 Animal studies have suggested the possibility of promoting HPC engraftment after myeloablative treatment by altering the expression of adhesion molecules through short-term ex vivo pretreatment of HPC with cytokines, 20, 21 although these data could not be confirmed by others. 22 In the current study the basis for this approach was further evaluated. Expression of adhesion molecules and adhesion itself was studied after short-term ex vivo incubation of cryopreserved HPC with either AB serum alone or addition of two different combinations of cytokines and with MGDF. The first combination containing G-CSF, SCF, IL-3 and IL-11 was chosen due to the growth-promoting activity and the known upregulation of adhesion molecules on HPC by these cytokines. 19, [23] [24] [25] [26] [27] [28] [29] Cytokine combinations such as the one used in our study have previously shown synergistic activity for ex vivo expansion of HPC. 30 The second cocktail contained the inflammatory cytokines IL-4, IL-1␤ and interferon-␥ which are able to downregulate adhesion molecules, mainly on stromal and endothelial cells. [31] [32] [33] [34] Thirdly, we analyzed the effects of the newly discovered cytokine MGDF with special attention to the expression of megakaryocytic adhesion and differentiation molecules.
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Materials and methods
Patient cell preparation
PBPC were obtained from patients with solid tumors during recovery from conventional chemotherapy and under rhGCSF-support (s.c. at 10 g/kg/per day). Leukapheresis was performed prior to high-dose therapy using a COBE (Heimstetten, Germany) Spectra cell separator. The patients' written informed consent for the experimental use of parts of the leukapheresis product was obtained beforehand. After collection, aliquots of cells were either immediately used for our study or frozen under controlled conditions and stored in liquid nitrogen at Ϫ196°C after resuspension in 10% dimethylsulfoxide (DMSO; SigmaAldrich, Deisenhofen, Germany). Cells were washed immediately after thawing with an excess of medium containing 10% AB serum in order to eliminate DMSO and therefore maintain viability before further processing. All centrifugation and staining steps described in the following sections until flow cytometry were done at 4°C, except for the separation step on the CD34 column which was performed at room temperature. The total duration of cell processing before flow cytometry was 2 h.
Antibodies used for flow-cytometry (FACS analysis)
The following FITC-conjugated or unconjugated (if indicated) monoclonal antibodies were used in this study to detect adhesion molecules: murine anti-human (mah)-CD49a (VLA-1) IgG1 from T-Cell-Diagnostics, Cambridge, MA, USA. From Dianova-Immunotech, Hamburg, Germany were: mah-CD29 (␤1-integrin subunit) IgG1, mah-CD49b (VLA-2 gpIa/IIa) IgG1 without FITC, mahCDw49c (VLA-3) IgG1, mah-CDw49d (VLA-4) IgG1, mah-CDw49e (VLA-5) IgG2b without FITC, rat-antimouse-CDw49f (VLA-6) IgG2a without FITC, mah-CD51 (␣ v chain; vitronectin receptor) IgG1 without FITC, mah-CD18 (␤ 2 integrin subunit), mah-CD61 (␤ 3 integrin subunit gpIIIa) IgG1 without FITC, mah-CD41 (gpIIb/IIIa) IgG1, mah-CD62P (GMP140) IgG1, mah-CD62L (LAM-1) IgG1, mah-CD44 (80-95 kDa) IgG1. Mah-CD104 (␤ 4 chain) IgG without FITC was from Biomol, Hamburg, Germany. MahCD11a, CD11b and CD11c IgG2a were from Becton Dickinson, Heidelberg, Germany.
The following control monoclonal antibodies were purchased from Dianova-Immunotech: non-conjugated and FITC-conjugated mouse IgG1, non-conjugated IgG2b and non-conjugated mouse IgG2a, FITC-conjugated F(abЈ) 2 fragment goat-anti-mouse IgG1 for indirect immunofluorescence. For negative controls we used IgG1-FITC/IgG2-PE. From Sigma-Aldrich we obtained FITC-conjugated goat-anti-rat IgG. The PE-conjugated monoclonal antibody directed against CD34 was anti-HPCA-2 (mouse IgG2a, Becton Dickinson).
Immunomagnetic purification of CD34
ϩ cells
Fresh or thawed leukapheresis products were enriched for the CD34 ϩ cell fraction by MACS-sorting (Miltenyi, Bergisch-Gladbach, Germany) according to the instructions of the manufacturer. A monoclonal antibody (QBEND/10, mouse IgG1), directed against the CD34 antigen and coupled to magnetic microbeads was used to label the cells. Up to 2 ϫ 10 9 cells were separated using a high gradient magnetic separation column (MSϩ) which was placed in a strong magnetic field. The magnetically labeled cells were retained in the column while non-labeled cells passed through. When the column was removed from the magnetic field, the magnetically retained cells were eluted. After isolation the purity was tested by flow cytometry using an anti-CD34 monoclonal antibody which binds to a distinct epitope (anti-HPCA-2). Purity of cryopreserved CD34 ϩ cells was 56 Ϯ 27% (mean Ϯ s.d.) (range 15-96%), and 81 Ϯ 19% for fresh cells (median 86%, range 42-99%). Viability after purification was 71 Ϯ 22% for cryopreserved CD34 ϩ cells, and 91 Ϯ 9% for fresh cells.
Dual colour flow cytometry
The surface expression of the CD34 antigen and of one adhesion molecule at a time were analyzed simultaneously. The MoAb against CD34 was phycoerythrin (PE)-conjugated while the monoclonal antibodies directed against adhesion molecules were either FITC-conjugated allowing direct immunofluorescence or non-conjugated requiring indirect immunofluorescence by the means of a FITClabeled secondary antibody. Cell labeling with the monoclonal antibodies was performed with at least 5 ϫ 10 5 cells per tube at 4°C for 30 min in the presence of human immunoglobulin (7S BehringInstitut, Marburg, Germany) and rabbit serum (SigmaAldrich).
Stained cells were washed twice with PBS/ 0.5%BSA/0.01% sodium azide to remove unbound antibody. Finally, propidium iodide (PI; Sigma-Aldrich) was added for 5 min. At least 3 ϫ 10 5 cells were used for each test. Using a FACScan cytofluorometer (Becton Dickinson, San José, CA, USA) the analysis was performed with Lysis II software. The fraction of PI-positive cells was quantitated and then excluded from further analysis. For every dual colour analysis negative controls were carried out by using the antibodies mentioned above in order to exclude nonspecific labeling, especially in cases when one MoAb was conjugated and others were non-conjugated.
Cytokines used for ex vivo incubation experiments
All cytokines were recombinant human and included G-CSF (Rhône-Poulenc Rorer, Köln, Germany), SCF (Amgen, Thousand Oaks, CA, USA), IL-3 (Behringwerke, Marburg, Germany), IL-11 (R&D Systems, Abingdon, UK), IL-4 (Immunex, Seattle, WA, USA), IL-1␤ (Biomol), interferon-␥ (Genzyme, Cambridge, MA, USA), and MGDF (Amgen). The colony-stimulating activity of MGDF and of SCF were confirmed in a methylcellulose assay with the MO7e cell line.
Ex vivo incubation experiments
After immunomagnetic purification, the cells were routinely incubated in petri dishes for 14 h at 0.5 ϫ 10 6 cells/ml in RPMI 1640 medium (Seromed, Berlin, Germany) containing either 20% AB serum (Red Cross, Berlin, Germany) alone or additional cytokines (as further specified in the result section) at 37°C in 100% humidity and at a constant CO 2 content of 5%. We did not use patients' sera in order to avoid pathologic cytokine contamination, especially by G-CSF which was administered before leukapheresis. Subsequent to the incubation, cells were collected for further analysis. Any adherent cells were removed by using a cell scraper. Viability was tested with trypan blue and the cells were stained for FACS analysis.
Adhesion experiments were carried out as previously described. 39 Plastic surfaces were prepared with one of the following extracellular matrix molecules (ECM) which were all purchased from Sigma-Aldrich: purified collagen type I and laminin from human placenta, collagen type IV from murine basement membrane, fibronectin and vitronectin from human plasma and vitronectin from human plasma cells. Bovine albumin, essentially globulin free from fraction V (Sigma-Aldrich) was used for determination of nonspecific binding. Ninety-six-well flat-bottom polystyrene plates (Nunc, Roskilde, Denmark) were either uncoated or were coated in quadruplicates for 90 min at 37°C with 50 l per well of dissolved collagen type I (2 g/ml in 0.02 m acetic acid), collagen type IV (2 g/ml in 0.02m acetic acid), laminin (20 g/ml in Tris-buffered NaCl), fibronectin (20 g/ml in 0.05 m Tris buffer pH 7.5), vitronectin (1 g/ml in distilled water) or BSA (1 mg/ml in distilled water). The remaining liquid was removed, and plates were used immediately for adhesion experiments.
MACS-sorted CD34 ϩ cells of Ͼ90% purity were radioactively labeled with chromium 51 Cr-EDTA (0.6-1.0 mg/ml, specific activity 700-1000 Ci/mg, radioactive concentration 90-110 Ci/ml; Amersham-Buchler, Braunschweig, Germany) in the presence of FCS (1:1 v/v) for 30 min at 37°C using approximately 50 Ci per 10 6 cells. Unbound radioactivity was removed by three washing steps in phosphate-buffered saline (PBS) prewarmed to room temperature and containing Ca 2ϩ and Mg 2ϩ (Gibco Life Technologies, Eggenstein, Germany). Cell viability was tested again and usually found to remain unchanged by the labeling procedure if fresh cells were used. However, with thawed leukapheresis products, the cell viability had decreased to less than 30% so that no adhesion experiments could be performed with these cells. Cells were resuspended at 0.5 ϫ 10 6 cells/ml in serum-free DMEM F12 (Gibco/Life Technologies, Paisley, UK), and 100 l cell suspension were put into each plastic well of the precoated microtiter plates. Cell adhesion was allowed to occur over 90 min at 37°C in a humidified atmosphere.
Thereafter, nonadherent cells were removed by three washing steps using PBS prewarmed to room temperature and containing Ca 2ϩ and Mg 2ϩ . Adherent cells were lysed with Triton X-100. In some wells the nonadherent cells were not removed in order to determine the signal for the total amount of cells per well. The lysates were collected individually using Macrowell tube strips and harvesting frames (Skatron Instruments, Lier, Norway) and were measured for radioactivity in a gamma counter (1272 Clinigramm, LKB Wallac). The supernatants from some of the wells containing adherent and nonadherent cells were collected without prior lysis in order to determine the spontaneous release of radioactivity. With the assumption that the labeling efficiency is identical for adherent and nonadherent cells, the fraction of adherent cells was calculated as follows:
% adherence = c.p.m. adhering to surface (total c.p.m.) Ϫ (spontaneously released c.p.m.) ϫ 100
Statistics
The adhesion molecule expression on cryopreserved HPC was studied by analyzing two different parameters: (1) the fraction of CD34 ϩ cells with expression of adhesion molecules and (2) the fluorescence intensity of the respective adhesion molecules. The change of both parameters after ex vivo incubation was analyzed by computing the Wilcoxon rank sum test for one sample data. For the one sample Wilcoxon signed rank test the 0-hypothesis is that the median of the increase distribution is given by 1.
40
Results
Expression of adhesion molecules on thawed HPC
We analyzed the expression of adhesion molecules immediately after thawing the buffy coat preparations. This time point correlates to the clinical situation at transplantation. After exclusion of dead cells with propidium iodide and gating for CD34 ϩ cells, 100% were positive for CD44, 67% for CD29, 55% for CD49d, 35% for CD18, 16% for CD49e, 16% for CD61, 12% for CD41, 11% for CD62L, and 6% for CD51 ( Figure 1 and Table 1 ). The integrin subunits CD49a, CD49b and CD49c as well as CD11a, CD11b and CD11c were not detected on the cell surface. The respective fluorescence intensities are indicated in Table 2 . These results show a marked heterogeneity for the expression of individual adhesion molecules on thawed CD34 + cells. Moreover, some adhesion molecules such as CD51 and CD61 are represented with a remarkable interindividual variability, as can be seen from the statistics in Tables 1 and 2 .
Expression of adhesion molecules on fresh HPC
Fresh CD34
ϩ cells express some adhesion molecules at a higher intensity, when compared to thawed CD34 ϩ cells, especially CD62L (Tables 1 and 2 ). Furthermore, fresh HPC showed a higher fluorescence intensity, expressed as mean channel number (MCN) in comparison to frozen samples in the case of CD29, CD62L and CD 49d ( Figure  2 ). The loss of fluorescence intensity reflects a decrease in the number of molecules expressed per cell. Due to the high interindividual variability of adhesion molecule expression, the statistical analysis between the two groups did not reach significance although such differences could be clearly shown in intraindividual experiments as demonstrated in Figure 2 . The fluorescence intensity of the HPC cell marker CD34 itself was not altered by freezing (data not shown). Taken together, some adhesion molecules are more susceptible to cryopreservation than others. However, fresh HPC also display a heterogeneous pattern of adhesion molecule expression. expression of CD29, CD62L and CD41 (Figure 3a and Table 1 ). The antigen density (mean channel number) of CD18, CD49d, CD49e and CD62L increased approximately to the level of fresh cells (Table 2) . For statistical analysis, the interindividual variability again necessitated intraindividual comparison between the expression without or with serum incubation. When the results from all adhesion molecules were compiled, the mean increase in fluorescence intensity after serum incubation was 2.7-fold with P = 0.008 (Figure 3b ). The fraction of CD34 ϩ cells with adhesion molecule expression increased 1.9-fold with P = 0.078. These findings show that the damage to adhesion molecules on CD34 ϩ cells caused by cryopreservation and thawing is not permanent, and can, at least in part, be restored within 14 h.
Effects of serum alone on adhesion molecule reexpression
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Effects of cytokines on adhesion molecule expression on thawed and fresh HPC
We searched for effects on the expression of adhesion molecules induced by cytokines. Thawed HPC were incubated at 37°C with 20% AB serum containing the cytokine combinations G-CSF ϩ SCF ϩ IL-3 ϩ IL-11, each at 100 ng/ml (cocktail I) or IL-4 at 10 ng/ml ϩ IL-1␤ at 1 ng/ml ϩ interferon-␥ at 100 U/ml (cocktail II) or MGDF alone at 100 ng/ml over 14 h. However, none of the combinations added to the effects of serum alone with respect to adhesion molecule expression as far as is analyzed in this study and as far as can be stated due to some variability of our data (Figure 3a, Tables 1 and 2 ). Previous time course experiments had been carried out from 10 min to 48 h with either serum alone or with the cytokine combination G-CSF ϩ SCF ϩ IL-3 ϩ IL-11 and did not yield further changes as compared to the 14 h incubation time (data not shown).
Effects of cytokines on the adhesion of fresh CD34 ϩ cells to various ECM proteins
In order to functionally test for the adhesive ability of HPC we measured the fraction of 51 Cr-labeled cells adhering to surfaces coated with individual soluble ECM proteins. These proteins have previously been shown to bind HPC via integrins or non-integrin adhesion receptors. [41] [42] [43] When analyzing purified CD34 ϩ cells from fresh buffy coat preparations (n = 4), control binding to BSA-coated plates was 5% in all experiments and was subtracted from the data of the various ECM molecules. The maximum fraction of CD34 ϩ cells adhering to ECM proteins was 18% for collagen type I, 20% for collagen type IV, 22% for fibronectin, 21% laminin and 11% for vitronectin. Unfortunately, thawed buffy coat preparations could not be tested for adhesion due to poor viability of these more fragile cells after the pretreatment which is required for this adhesion experiment. The relevance of short-term cytokine exposure on the adhesion of hematopoietic progenitor cells to ECM proteins was also tested. Freshly purified CD34 ϩ cells (n = 4) were incubated for 14 h with either 10% AB serum alone or the cytokine combinations G-CSF ϩ SCF ϩ IL-3 ϩ IL-11 or IL-4 ϩ IL-1␤ ϩ IFN-␥ or MGDF alone at the concentrations which we had used for the FACS experiments. However, when compared to preincubation with serum, the fraction of fresh CD34
ϩ cells adhering to collagen type I or IV, or fibronectin or laminin or vitronectin remained basically identical regardless of the cytokines used for preincubation.
Discussion
We examined the pattern of adhesion molecule expression on cryopreserved HPC which resembles the clinical situ- ation at the time of transplantation. A marked heterogeneity was observed with respect to the fraction of CD34 ϩ cells with integrin subunits on the surface, with the strongest expression of CD29, CD49d and CD18. To our knowledge, this is the first report in the literature on adhesion molecule expression on cryopreserved HPC.
When compared to fresh HPC we saw that some but not all surface adhesion molecules are susceptible to the effect of cryopreservation and thawing. The reduction mainly in fluorescence intensity demonstrates that this damage is not complete but partial in the sense that the density of these receptors per cell is reduced with no major alterations in the percentage of CD34
ϩ cells with expression of adhesion molecules. In the case of CD62L, however, not only the surface density but also the fraction of CD62L ϩ cells is reduced, showing a special susceptibility of this molecule. Rapid shedding of CD62L from the cell surface of neutrophils, monocytes, and myeloid precursor cells has been previously reported after exposure to GM-CSF and other neutrophil activators. 13, 44 The HPC marker CD34 which has also a potential role as an adhesion molecule 45, 46 remained remarkably unchanged after cryopreservation. The stability of this molecule allows the unrestricted flow-cytometric quantitation which is useful for the quality control of the graft.
A recovery from cyropreservation damage could be most clearly shown for CD62L as well as for CD29. Time course experiments showed that re-expression of these molecules starts within 6 h of serum incubation with a maximum at 12 h (data not shown). The rapidity of adhesion molecule recovery would still allow for these molecules to be functionally involved in the homing process despite the damage induced by cryopreservation, although such a role cannot be concluded from this study. When HSA only was used instead of serum, adhesion molecules were not re-expressed (data not shown) showing that serum is both necessary and sufficient for the restitution of HPC after cryopreservation. It is likely that that adhesion molecules in vivo after transplantation are restored in a similar way as in vitro. Therefore, despite the irreversible damage that occurs to a part of HPC during cryopreservation 7, 8 qualitative changes of the remaining viable cells seem to be reversible, which probably explains the successful restoration of hematopoiesis which is usually seen after myeloablative therapy.
We were interested to see whether a short-term exposure of HPC to cytokines might induce overexpression of adhesion molecules and thereby potentially foster the engraftment process. 20, 21 In this context, rapid platelet recovery after peripheral blood stem cell transplantation has been associated with the expression of CD62L on the CD34 ϩ cells of the graft. 47 Our results show that a 14 h incubation with high concentrations of the two cytokine combinations or MGDF alone did not alter the expression of adhesion molecules nor adhesion itself to various ECM molecules as far as is analyzed in this study. Due to limitations in the availability of fresh cells this observation can only be stated for cryopreserved material. Since it was not the focus of this paper to study the effect of individual cytokines, experiments under serum-free conditions have not been performed. However, our data are compatible with the literature where treatment of MO7e cells with SCF produced only a transient increase in adherence to human umbilical vein endothelial cells or to vascular cell adhesion molecule l-transfected Chinese hamster ovary cells with peak adhesion at 30 min and return to baseline by 60-90 min. 25 Similarly, a transient fibronectin-adherent phenotype with increased VLA-4 and VLA-5 avidity was induced with cell lines including MO7e and freshly obtained CD34 ϩ cells from bone marrow after 30 min exposure to a cytokine cocktail comprising IL-3, GM-CSF and SCF. 48 The latter cytokines are also known to rapidly induce adhesiveness of HPC to hyaluronan via CD44. 49 Rapid changes have been earlier reported for the expression of CD18 and CD62L on HPC after treatment with G-CSF and GM-CSF. 23, 50 Other recently published results on the upregulation of CD41 and adhesion to fibronectin 38 are also compatible with our data since these authors reported a 6 day incubation time to be required for maximal induction of the adhesion molecule. Somewhat in contrast to our results are reports on an increase in CD49e-mediated adhesion of murine multipotent cell lines to different chymotryptic fragments of fibronectin after 2-9 h of preincubation with IL-3.
26,27 These differences, however, might be due to the different cell species. Also, we would like to add, that by combining the cytokines in our study individual effects might have been masked through possible complementarity of action. A very rapid and temporary upregulation of adhesion molecules may be sufficient for the initial phase of bone marrow invasion after transplantation. Recently, a two-step model of cytokine regulation has been proposed explaining an initial activation of adhesion molecules which is then followed by cell proliferation. 48 Sustained residence of HPC within the bone marrow may then be mediated by other adhesion molecules and other ECM molecules like the recently described HEMCAM. 51 We like to speculate that refractoriness of HPC to short-term changes of cytokine concentrations as described in this paper might be a physiological mechanism of protecting long-term haematopoiesis.
